糖尿病眼病实践指南的系统评价:适用性、透明度和开发严谨性有待提高
该研究系统检索六个数据库和指南库,用AGREE II工具由四名评价者独立评估18部糖尿病眼病临床实践指南的质量。结果显示指南方法学质量差异大,仅9部(均为循证指南)达「良好质量」,适用性领域得分最低。
要点
- 糖尿病眼病指南方法学质量差异显著,仅半数达良好质量。
- 适用性领域得分中位数仅28.6%,为各领域最低。
- 循证指南评分显著高于专家共识指南。
核心结论
- 糖尿病眼病指南方法学质量差异大,9部循证指南达「良好质量」。
- 未来指南应改善利益相关方参与、开发严谨性、临床应用支持和编辑透明度。
研究设计与样本
- 系统检索六个在线数据库和指南库中的糖尿病眼病指南。
- 四名评价者独立使用AGREE II工具评分,计算六个领域聚合得分及总体质量评估。
- 共纳入18部指南,其中13部为循证指南(涉及系统检索和证据分级)。
主要发现
- 「范围和目的」中位得分73.6%(IQR 54.2%-80.6%)。
- 「利益相关方参与」中位得分48.6%(IQR 29.2%-71.5%)。
- 「开发严谨性」中位得分60.2%(IQR 30.9%-78.1%)。
- 「表述清晰性」中位得分86.6%(IQR 76.7%-94.4%),「适用性」中位得分28.6%(IQR 18.0%-37.8%),「编辑独立性」中位得分60.2%(IQR 30.9%-78.1%)。
- 全部指南总体评分中位数为5.1分(满分7,IQR 3.7-5.8),循证指南评分显著高于专家共识指南,9部(均为循证指南)达「良好质量」。
关键数值与推荐
- 「良好质量」指南定义为「开发严谨性」得分≥60%且至少两个其他领域得分≥60%。
临床怎么用
- 临床选用糖尿病眼病指南时可参考AGREE II评分,优先选择循证且方法学质量达「良好质量」的指南。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To assess the quality of diabetic eye disease clinical practice guidelines. STUDY DESIGN AND SETTING: A systematic search of diabetic eye disease guidelines was conducted on six online databases and guideline repositories. Four reviewers independently rated quality using the Appraisal of Guidelines, Research, and Evaluation (AGREE II) instrument. Aggregate scores (%) for six domains and overall quality assessment were calculated. A "good quality" guideline was one with ≥60% score for "rigor of development" and in at least two other domains. RESULTS: Eighteen guidelines met the inclusion criteria, of which 13 were evidence-based guidelines (involved systematic search and grading of evidence). The median scores (interquartile range (IQR)) for "scope and purpose," "stakeholder involvement," "rigor of development," "clarity of presentation," "applicability" and "editorial independence" were 73.6% (54.2%-80.6%), 48.6% (29.2%-71.5%), 60.2% (30.9%-78.1%), 86.6% (76.7%-94.4%), 28.6% (18.0%-37.8%) and 60.2% (30.9%-78.1%), respectively. The median overall score (out of 7) of all guidelines was 5.1 (IQR: 3.7-5.8). Evidence-based guidelines scored significantly higher compared to expert-consensus guidelines. Half (n = 9) of the guidelines (all evidence-based) were of "good quality." CONCLUSION: A wide variation in methodological quality exists among diabetic eyecare guidelines, with nine demonstrating "good quality." Future iterations of guidelines could improve by appropriately engaging stakeholders, following a rigorous development process, including support for application in clinical practice and ensuring editorial transparency.
引用
- Gyawali R, Toomey M, Stapleton F, et al. Systematic review of diabetic eye disease practice guidelines: more applicability, transparency and development rigor are needed. J Clin Epidemiol. 2021. PMID: 34487836. doi:10.1016/j.jclinepi.2021.08.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。